Can Google’s Pixel Watch compete with Apple on health?

You are reading the web version of STAT Health Tech, our guide to how technology is changing the life sciences. Sign up to receive this newsletter in your inbox every Tuesday and Thursday.

Mental health tech companies are preparing for the Food and Drug Administration (FDA) to tighten restrictions

In April 2020, . was released Food and Drug Administration He announced an emergency policy that gives companies ample leeway to launch apps to tackle a mental health crisis that experts fear will only get worse under lockdown. It has been a boon for startups developing digital treatments for depression, ADHD, substance abuse, and other conditions. In the years since, they have been able to test drive their products in the real world without seeking marketing authorization from the Food and Drug Administration, which would require years of expensive clinical trials.

advertisement

Now, companies that have taken advantage of the freedom to develop their product pipelines are watching with alarm as the Food and Drug Administration (FDA) prepares to roll back provisions. Mario took a closer look at how you like companies limpixAnd frisperAnd great healthand others wrestle.

Big push for telehealth at Address X

advertisement

The Department of Health and Human Services Donate more than $16 million in grants to groups focused on expanding virtual care at Title X family planning clinics across the country — an effort by Biden Managing to preserve reproductive care as the Supreme Court appears ready to overturn Roe v. Wade and as states move to restrict abortions. HHS Secretary Xavier Becerra She said. The money comes from the US bailout and one-year support projects starting in mid-May.

Can Google’s Pixel Watch beat Apple?

The Google On Wednesday, it showed off the long-rumored Pixel Watch at Google I/O, the company’s annual developer conference. Senior Vice President of Equipment and Services Rick Osterloh Detailed some features including activity and fitness tracking features of FitbitWhich The Google acquired last year. Although the company has produced an Android wearable operating system, Wear OS, since 2014, this is Google’s first attempt to develop a smartwatch in-house.

Google is way behind the smartwatch game and there are many unanswered questions. How will Google make up for what it lost apple, who spent seven years building her Watch Health Functions and establishing connections with research organizations? Given how important the health function of wearable marketing is, can Google sell a message about health after restructuring its health unit? Or can a smartwatch succeed without a strong health angle? Osterloh said there will be more details about the Pixel Watch – which launches this fall – in the coming months.

Hims & Hers earnings exceed expectations

Virtual care has seen mixed results on Wall Street as bustling companies struggle to make telehealth profitable. While Teladoc stumbled last month, hustle and bustleThe direct-to-consumer provider of hair loss medications, contraceptives, and skin care products, exceeded expectations this quarter and even revised upward its revenue guidance for the year. The first quarter of 2022 generated $101.3 million in revenue, nearly double the first quarter of the previous year.

The growth was driven by the company’s largest-ever quarterly gain in subscriptions – shown in the above slide from Hims & Hers Investors Group – which drove subscriptions to over 710,000. The company has also recently doubled down on the skincare offerings it has worked with Goodpath On sleep tutorials and common issues, share with them carbon To provide personalized primary care.

A better approach to medical artificial intelligence?

More and more research is focusing on the ways medical models can introduce algorithmic bias in health care. But in a new paper, machine learning researchers caution that such self-reflection is often ad hoc and incomplete. They argue that to have an “unbiased judgment about AI bias” there needs to be a more routine and robust way to analyze how algorithms perform. Without a standardized process, researchers will only find the bias they think they are looking for. To make this possible, researchers are introducing a new framework designed to aid in the systematic and comprehensive assessment of declines in performance. Read Katie’s new story about the effort here.

Deals and Partnerships

  • blue medical notewhich is developing prescription digital therapies for cancer-related anxiety and depression, has signed a deal with them Bixink . Treatmentswhich will market its products in South Korea. It is the latest such licensing deal to move US-developed products to Asia.
  • turquoise healtha startup that handles healthcare pricing and contracting, raised $20 million Series A from Andreessen Horowitz Posted by Bessemer, Box GroupAnd Tiger Global.

Names in the news

the alphabet Company Similar LabsWhich aims to use machine learning to discover drugs Miles Congrave As the chief scientific officer, Sergey Yeknin As Chief Technology Officer, Max Jaderberg As a machine learning manager, and Alexandra Richenberg As a Personnel Operations Manager. Congreve most recently served as Chief Scientific Officer of Susi Heptars; He was the head of the technology department at Sophia’s genes; Jaderberg was a research scientist at deep mindand Reichenburg was the senior vice president of people at Eigen . Technologies.

what we read

  • Remote healthy abortion pill providers targeted by US activists, The Financial Times
  • Hundreds of patient data breaches left unpunished, The BMJ
  • Oscar Health Leaves Two States Amid Business and Regulatory Challenges, Modern Healthcare
  • A new biotech investment firm, headed by a couple of noteworthy venture capitalists, seeks to ‘liberate the founders’, STAT

Leave a Comment

Your email address will not be published.